Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daklinza and Metformin Interaction Study
NCT02565862Phase 1Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2016
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of daclatasvir in hepatitis C (HCV), sponsored by Radboud University Medical Center. Primary endpoint: Area Under the Curve at 24 hours. Started Jan 2016; status: completed.
02
Drugs
daclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02565862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02565862.